The Joint (JYNT)
(Delayed Data from NSDQ)
$12.32 USD
+0.09 (0.74%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $12.31 -0.01 (-0.08%) 5:50 PM ET
3-Hold of 5 3
B Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
JYNT 12.32 +0.09(0.74%)
Will JYNT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for JYNT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JYNT
The Joint Corp. (JYNT) Upgraded to Buy: What Does It Mean for the Stock?
The Joint Corp. (JYNT) Moves 10.1% Higher: Will This Strength Last?
JYNT: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics
The Joint Corp. (JYNT) Q4 Earnings and Revenues Top Estimates
The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers
Other News for JYNT
The Joint Corp. Switches Its Focus To Profitability
The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results
The Joint Chiropractic Proudly Supports Colorado-Based Rachel's Challenge
Logan University Establishes The Joint Chiropractic Endowed Scholarship
Joint Corp participates in a conference call with Lake Street